Cost-effectiveness of Cetuximab as a treatment strategy for metastatic colon cancer in Peru: chemotherapy/Cetuximab versus chemotherapy alone

Rafael Bolaños-Díaz, César Sanabria-Montañez, Carlos Farfán-Tello, María Calderón-Cahua

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Cost-effectiveness of Cetuximab as a treatment strategy for metastatic colon cancer in Peru: chemotherapy/Cetuximab versus chemotherapy alone'. Together they form a unique fingerprint.

Business & Economics

Medicine & Life Sciences

Chemical Compounds